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Northern blot analysh of hunlnn luntt tUlttOr~ indicated that the t~n¢, which ¢nt'ode~ th  ubllllsin-tlke pl~pml~in pt~'cs~iilll tm~¢ I~'I#IK'3. 
was hitlllly e,Mw~,~,~ed hi ahnost ill cat~inold tumors limed, In ,nlltll tell lun8 carclnomn~ {SCLC~I, ¢~pre~don varied, in non..SCL(.3t a ttl normal 
hut[l, no expression wl~ rotmd. Analysts of SCLC tell lines rcveMed that c,sprc~sion was rgstr~tod pr¢l'er~ntially Io cell lines of the clas~.tl t~pe. 
In hln[t tllmor cclh expressing the PCI/I~',~ ~ell¢, trattsCl'Lpls o1' 3 kb ,tad 5 kb w~re detected, the 5 kb mRNA al~,a.~,~ heht8 the mo~t tblatda~t 
Sl~.',cl¢~, We tsohlt~:tt it eDNA corn~spoadhl$ to the S kb human 1N21/1¢3 tnmwrlpt, determined the nucleotlde soquenc~ ol'it and deduc~M the amino 
add sequence of the corr¢spondinB iwoteln. Furthermo~. we ct~ndude that the wo ~1/~3 transcripts htls~ 3' uon~t~ltn8 n.'~itms of diffC-t~|t 
s [~ Illtt| t.?llk't'Kl~ the san',¢ I'~rt~t¢in. 
Subllllshl-llke paq~mtcln I~lX~'~.~sht~ ¢t 'a~e; I~'1~1~C~ truman 1u1~ tumor 
I, INTRODUCTION 
Recently, the dis~.~ox~ry o1"the coding sequences for
a nuln~r of new nuunmalian endoproteolytie prt~'¢~s- 
i~  enzymes was reported [1~1. The enz~nes were 
named furin [13], PCI [4,71. PC2 [4,51 and PC3 [6,8]. 
Two groups independently discovet~.'d the coding se- 
quences tbr the same mou.,'e nzyrne, As a I~esult, dil)~er- 
ent nalnes were assignat, one group calh.,d the enzyme 
PC1 [4.71, the other named it PC3 [61. 10 avoid confu- 
sion here. tt~ will rel'cr to this enzyme as PCI!PC3. The 
newly discovct~.xt enz~:nlcs wet~ dcmonstt~tt~ to exhibit 
cleavage s~'cilicity t'~ sites SlC,.-cified by particnlar se- 
quences ol basic amino acid residues: most I'rcquently 
p'tired basic residues (Ly~-Arg ~r At&Arg), 
The fnrin enzyme, which can be considered as the 
mammalian prototype, is encoded by the ,li,,r gcne [I] 
and was found widely express~ [9-,I I l, The coding se- 
qnencc of the human [31, mouse [10l and mt [121 rio" 
genes have been fully ciaat~tcterized and flit-like genes 
have b.'cn isolated from D~vop/zila mt, hmogaster, Dfitrl 
and D/to'2 [I 3}, and Caenorhabditis elegans, bli-4 [14], 
Malnmalian furin appeared capable to correctly process 
the precursor of yon Willebrand factor [ 15,16], fl-nervc 
growth t~actor [17], proalbumin [181 and complement 
pro-C3 (the third component of complement) [18]. As 
('orrc.V~otrdcnc¢ athbess: J.W.M, Crccmers, Moh,-cular Oneology Scc- 
rio11, Center for Fluman Genetics, University or" Leuvcn, Hcrestraat 
49, B-3000 Leuvcn, Belgium, 
far ns the two other tlcwly dis~ox~red cn~Tn~ arc c~m- 
eerncd, the coding ~'quenc~ of mouse PCl/I~"3 [6-8] 
and those of human [5] aud ,uon~ [41 PC2 haw also 
been fully characterized. The genes which encode the 
I~I/PC3 and !~2 proteins hax~e recently bccn desig- 
nated as NEC! and NE~,  respcctix~ely [19]. They seem 
to have an expre&sion l~ttera thai is r~trictcd to endo- 
crine and tleural tissue [4,6], PCI /PC3 and PC2 
appeared capable of corr~lly cleaving the multifunc. 
tional precursor protein proopiomelanc~.-ortin, each al 
distinct pairs of basic residues [20,21]. Structurally and 
t'nnctionally, the th~-c new en~mlcs ch, ,ely r~:cmble :ire 
prohormone proee~ing end, me Kex2 which is encoded 
by the KE,12 gene ot" ~.~::~ Sa, 'ban.,,'~3~,s re~'~qsim'. 
Kex2 is a membrane-a~ccia~.ed 2,L~'4.::~ndent, subli- 
lisin-like serine endoprolea,~ with a neutral pH op- 
timmn [22], In the primal, translational product of 
KE,/~ . gene, a number of domains have been defined: a
'prepro' domain, a subtilisin-like ~atalytic domain, a 'P' 
domain which is critical for catalytic activity, a serine/ 
threonine-rich region, a tmnsmembrane anchor and a 
small cytoplasmic tail [2,23]. Similar domains are also 
found in fnrin, except hat fitrin has no serine/threoaine- 
rich region but a cysteinc-rich region just preceding a 
prcsnmptive transmembrane domain [If,15]. Using 
computer-assisted molecular modelling with data of 
known members of the subtilisin-like family of serine 
proteases [24], a model for the catalytic domain of furin 
was proposed [! 5]. The enzymes PC 1/PC3 and PC2 :~,,- 
parently lack a serine/threonine- and a cysteine-rich 
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region. Furtltermo~. they also do not possess a car- 
boxy-tcrminal hydrophobic region that could act as a 
transmcmbranc anchor; however, association with 
SCLC ~II  lines (National Cancer Institute ~'tles) were oblained from 
D.N. Carney. 
"t '$ I~ I  J I*,.J.,t,~.,*~ ...i ~.~.* J , , .~  &L.*  . . . . .  h , . . t , .  
- - I  " * : . . .  ~ :~.  : . : . . , , .  ~: . : :  : : : s  8 ycoprot¢lns of  vlrai i~!th0~ns, !: : : ::: 
While the/ongi~sterious identity of  the mammaUan 
enzymes t'~,ponstbl~ for:.propmtein p~ss ins  (snow 
readily b¢in$ uncovered, tt Is or int¢~st to estttbli~h the 
desr~ ol on~ni0 diversity in thi, nov01iand ,till mnall 
cn~vnte {hnttly. Since some cl¢~waSe ~t1|CdlCgttre still 
unaccounted Ibr, discovery of additional members of 
this gCllC lhmily nliBht be expected, However, some of 
the enzyme diversity misht also be obtained via alterna- 
tive splicing by which the presence or absence l" parti- 
~,ular dontains is controll~ and 0n~,me s~if lcmions 
dctemtined, In Nonhero blot almlYsi~ o[ n~urocndo. 
trine tissues, I~l/PC3-spc, iflc mRNA species of 3 kb 
and $ kb [5,8] were det~ted, appAtrel~t~ with the 3 kb 
transcript as the more abundant one. Sintilarly, expres- 
sion oi" the D ii..I 8¢ne o1" D~)sophila .wlanogaswr re- 
vealed transcripts el" 4,0, 4,5 attd 6,5 kb [13]. Detailed 
analysis of these Dli.'l transcripts revealed that the 
obserx~.xl dil't~rences bet~.'ctt hem were partly due to 
altematix~ splicit~l which resulted in protein diversity 
(Roebroek et al, in prel~tration), in this report, ~ char- 
actcrizc the coding sequences of huiuan PCIIPC3 arid 
dclhte the molecular b~sis I'or the dillbrences bet~x~n 
the 3 kb attd 5 kb PClIPC3 ttxtnscripts, To at.xxmlplish 
this, we have Ih'sl search~.xl for hun~tan cells that pre- 
ibt~ntially exptxss~xt the 5 kb tntnscript el" NEC[, Snb- 
scquently, we isohth.'d and ~'~ol~.~ularly ~:har, tcterized a
eDNA clone correspondi~g to this 5 kb human NECi 
tnmscript and ~.x~mpatx'd the data to those era  mouse 
PCi !PC3 eDNA clone cort-.~spending to th2 3 kb trans- 
cript, 
carclnold tumor o['the luns.l~ oltllo(dT~,!lulo~ a l l l a i t~:~lcq~ 
u Mn8 u Pharm~flia/LKB ~DNA st)mthe~d~ kit; About | ~I0,000 
obtumm upon latvian el" ~sv#we/~/a ta/lY lOgO ~ ~ . ~  
the 2.6 kb mou~ I~$ eDNA 161 M U molecular ~ whldl .~  
ktndl)' provided by O. ~1¢|~, ~ical~ l~'Idi~I~ eM~t~ o~ 
nlttoccllulo~ mc, mbmn¢~ were ~ it  p~'tou~ deserilsed 
l-'Sl. 
2,4. A'uc/~,/de ,w~c~v ~/y.~l~ 
Nu¢leotlde sequence5 ~ ~k'lcrmined ~¢coMin8 to the dkkx~ ~ 
chain termination mclhod uslnB the T'/I~)mcra~ '~ue~-i~ ka of 
Phannact~tLKll, The DNA I~qgnents Io b¢ ~ucn¢~ w¢~ 
kb 
1 2 3 4 5 6 T 8 9 
~',o - -  
o .~ _ 
2, MATERIALS AND METItODS 
2, I. Prmu,3' hmg tumor,~ ami h.~g ¢'arci~hm~ it'll li~c,~ 
Lung carcinoma slx, cimens I~'ml 24 t'~l, tients ~rc  selected I'tx~m the 
tlh.~ of the ~Rhology Department of the St. Antonius Hospital, Nieu- 
x~gein, The Netherlands, S1x'c~mens ~x~.le prcs.'csscd as dcs.'cri~xt 
before [25]. Tun~ors ~vcrc haracterized by routine microscopical nd 
histopathological techniques and cla~sili~.xt ao.'ording to the criteria of 
the WHO [26] as SCLC (6 ¢ascs'L carcinoid tumors (5 eases} or non- 
SCLC (t 3 cases). 
The ecll lines usuxl in this study were all established human SCLC 
cell lines, which have bec, de~efi~'d before [25]. The SCIC txql lines 
GLC-I and GLC-I-M13 ~re  obtaimM fi'om L. de Leij. and the cell 
lines SCLC-16HC, SCLC-16HV, SCLC.21H, and SCLC-22E from 
G. Bcpler. NL-SCLC3 wes obtaimM from J. Btx~rs [27]./2: other 
l , o - -  
and lung tumo~ Nonhero blot analysis ~ ~o~ ~ith total 
RNA (amoums o1" I S/~g) isolated from the SCLC cell ines NCI-H.--q9 
0ane t) and NL-SCLC3 ~Iane 2). tx~o primary human SCLCs (lanes 
3 and 4), two ~rcinoid tumors fth¢ tung (lanes 5and 6). txx~ prima~- 
non-.SCtCs (hines 7 and ~). or normal human lung ttanc 9)..As a 
molecular p obe, a 2.6 kb mouse PCI/PC3 eDNA was used. Using 
intensi~'ing sc~n~ eXl~surc time of X.ray fihns was 40 h. The posi- 
tions of the hmlceular ~ight markers. Hmdlll-<ligcstcd 3 DNA. arc 
indicated. Incontrol expcrimems, blots were dehybddizcd and subse- 
quently hybridized with a hamster actin eDNA probe [25] under sim- 
ilar conditions a  described abo~. Exposure lime of X-my films was 
20 h. kb. kilobase. 
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AAGG~1XCACI"GAGCGO~GCCTCTCCTCTCGCGCCTCCTAGCTC TTCGCAGAGCAACCAGGA~G~I~~~~G~ 120 
1~TTTT~TCCTATCTTGCTTCTTTTTCCT~TTCCCTTCCCACTCTT~TTCAAGC~G1.GTGT~AGCTATGGA~~6~G~~~ 240 
TA'I~CC~CTATQATCCJ~3CTAQCI"AT~TTTTAAT~TAA ~T~CCATaATCCAT T--~,~CCUATA~ . . . . . .  ~ ~ ~  
211' 
~TCCAI~i i  C,~TC I~QOC~C~TC~aATAAI"TQNTGI~ATOQCT~P~TACAC~ig i~~~ lEO0 
CACACA( I~ACCTC~CTCT~ACCTCT~CT~ITCTTC~TCT~CCC~BAE~Dk/~OCC~I~I&~~~TM 1440 
GAC,~-~G~TOBCCAATAACCCT~AI~OAAA~G~ATO~A~A~TTGAT~TGAATAGTCGA~~~T~~~~ 1~0 
H R $ V P E K ~ E C V V K 0 N 0 F E P R A L K A N G E V I I E | ~ T R A C E G Q 4~? 
GAKI, A 'T~CT&I"C I~TCCCT(~LCET~T&CAATTTGAA~C/~.~TATTCCCOAA~~~~~~~ 1800 
E N A I K $ L E H V Q F E A T ~ E Y $ R R G O L H V T k T S A A G T $ T V I.. L A 5,3~ 
GAA~P~`CG~`~TACATCTCCTAATGG~TTTA~p`C`~AC~p~ACTTCA~~~~TATA~T~~~~ tg, L'O 
E R E R b T $ P N G F K N ~ O F H $ V H T M G E N P | G T M T t. R | T O N $ G R $'~ 
ATTC~NU~TCJU~GC~AC~ATTGTC~J~cTGGAAG~;1GATTTTGCACGGG~CCT~~T~~~T~T~~~ Lr~40 
I q N E G R i V N ~1K k I L H G T S S Q P E H H K Q p R V Y T S V N T V q N O ~ 617 
AP~(;~G~P~J~AC~AI"~TCCA~iAC~A~,AGCCCACACAAC-~AGAACCCTAA~GA~I ~ ~ ~ ~  t ~ ~ ~  21.60 
'~ G V E K M V O P G E E Q P T Q E N P K E N T L V $ K S P S S $ S V G C R R O E 657 
TTGGAG~GGGAC-CCL~TTL'L"CAG~CCATC-C'~'fL'~,aACTCCTGC~ AAGT~C ~ G T ~ C ~ ~ ~ ~  ~ ~ ~ ~ T  2260 
t- E E G A P ~; Q A M L R L L Q ~ ~, F $ K H $ P P K Q S p IC K $ P $ A K k N ~ P Y 697 
GAA.~CTTCTACGAAGCCC I"GGAAAAGCTCAACAJ~CCTTCCC~CTTA~.~C~~G~T A T ~ C T ~  ~ ~ ~ i~T~p~ ~* ~ ~T r~ ~  ~,~G. 
E N F Y E A L E K L N K P $ q k K 0 S E O S I. Y N O Y V 0 'q ,"- Y N '~ K p '~ ~ H R 73? 
GACC~C'~'~GCT~TTC.N~GCTCT~iTGGACATT~TGAMC~~~ATAAGTGTGTGG~G~TA~~A~T~i  i i I~-~',~'i~'TGTG ~5~0 
I> R L_L o A L~v o t~C t~,,~ E t~--*-- ~s3 
M~TI~TTGTTT~TCA'rG~TTCTTAT~TTATAATATCCTTTGT(;GCACCTTTTCTTTTTC 1 C C C T ~ C ~ T A ~ ~ ~ ~ G ~ C ~  Z~IO 
TTC~T~-ATA~TATTTC~-a-~,C, A ATCTTTCCTGTCTGCAC-~AGTGAAG~~~ ~ G ~ ~ ~ A ~ C T A ~ A ~ ~ A ~  2760 
ATT~CAA1~TCTCAAAAGAAAA~CA~ACCTGGGATATCAATrAp`TTTGAAAACATN~TC~GAATC~C~A~~C~i ~.  T A ~ ~ ~ ~  2~ 
TGGTT` CTTCAAMTTTGATGCCAAC` 4u~AGTATTTC~TAP~GCCTAATGAAGGAGTTCAC1~GTAAGACTCATrCCCTA~ ~ C T A ~ G ~ C ~ T A G ~  3COO 
TGGTCATGTTGGTCNU~GCTCaGMTATTTAGATCTAGA/~CAGATCTTCdU~TC~TGCTCT~~ i 1 tCGAACATTC~i~GCCTGGTGCACTGTGTCTGTGGTGCC.AG 3170 
AC```~CG~`~X~GATCCAGAGGTGGTTAT~CTCGTGCTGCATGCCTC~TCTTTCC~1~~G~TATA~~~T~~ 3240 
AGAAATC~TATATACC..ACTTTCCCAGAAAAA.ed~u~CTTACACTTGGGACTTGGCAAATTCCTAGTCACAATT~ I I ! iCAC.-.-.-.-.-.-.-.-.~AGTAACA~CCACTTATCACATGGAGACCTAATG 3360 
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¢ioned in the pKUNI9 or pGEM-3Zf(+) vt.~lor a.d sequenced using 
standard primers and printers synthesized based upon newly obtained 
sequences. The seqtlellt,~s werf obtained flora both strands and 
analyzed using the sequeno~ analysis compuler programs Genepm 
(Riverside s¢i¢n1111¢), l~/Gcne a.d Intelligenctics (InltclllGcnclics, 
Inc,). : . . . . . .  
ferentially express the 3 kb transcript. As far as the 
eDNA clones isolated from the ART-20 eDNA library 
are concerned, no conclusion could Ix: drawn as to 
3, RESULTS AND DISCUSSION 
The objective of this study was to i characterize the 
codingse~ucnccs el'the human I~I/PC3 ~ene, to define 
the molecular b.sis For the observed ivergent, in size 
el'the mt~jormRNA sp~ies .transcribed from this 8one, 
andto  evaluate the [mss|ble implications or this-d|. 
vergence for the proteins that miliht be encoded by the 
I~I/PC3: tuRN/~. Expression of. the. PCI/i~3 8one, 
which is apparently restrieted to cells el' endocrine and 
neural origin, apparently results in two mt~jor 
transcripts, as has b~n repro'ted beror¢ [4,6]; one of 
about 3 kb, the other of about 5 kb. In studies described 
solar, the 3 kb transcript was very often the most 
abundant o1' the two PCI/PC3 transcripts. An excep- 
tion, in this respect, constituted for example mouse pi- 
tuitary corticotmph AtT~0 cells, in these cells, similar 
levels or" the 3 kb and 5 kb transcripts were detected in 
one study [6]: low levels el'the 5 kb transcript, however, 
were reported in another study [4], The nuclcotide at.',. 
quence l'mouse PCI/PC3 cDNAs orabout 2.5 kb have 
been reported by several groups [6-8]. These cDNAs 
were isolated either from eDNA libraries erA|T-20 cells 
[6,8] or mouse insulinoma (.81"3) c~lls [7]: ~'T3 cells pre- 
lane are.  nown to ::disp   neu d ,  r atu  
therefore, they misht exp~ ~d, ly  detectable !¢~ of 
PC I/PC3 mRNAs, in FiB, :1, results of Nor t~ 
analysis are shown to illustrate the lev¢l~ of|he 3 kb~ : 
5 kb trancripts of PCItPC3, A~ molecular probe, a 
mouse PCI/PC3 eDNA prol~ orabout 2,6 kb~ ~ 
the actin mRNA levels m the ~rious ~m~ a~ 
as a control,T  all No.  
meats arc summarized in Table i and Table IL Initial~., 
studies v,~re pcrrormed with a ~ricty of ~l l -d¢f in~ 
c¢11 lines deri~l  ft'om human small ct~ll I~  ~ar,- 
cinemas (Table I). Expression of PCItPC3 transoripts 
or 3 kb and 5 kb were readily detectable in SCLC 
T~T~XAP~-A.TACT~TMTA~g~OU~GAP~d~G1  ~ 1~ 11 TTGT~CTGTGT'O~TTA~P.~TGT~AJ~TAi~ ~ f~G;TTT&TT~ 
GAT~CTA.au~GTTC TC T~?,AAT~'UTA TCACTGATAG'i'G~T T~ T C A C C ~ U ~ T T ~ C ~ T ~ T ~ ~ ~ ~ ~ ~ ~  
TA~T TtTGTTTf,~TAT?.~7,AP~I~ATGTTTTTAAAATATC~AGT~7~TTA ~TATf i~T~TT ~ ~ T ~ ~ ~ ~ ~ ~ ~  3~..~ O 
GAGTA~e,.~A~TC~'C TGATTAP~TGACTCTCAG~T(~.A~t2C T~T~Je~TGTTA~TA~C~~ ~ T A ~ T A ~  i i ,~  ~ t ~ ,,~O,.~T 
IL"CTA CACTAA~CT~J~TGTGTAP.J4AAGTGTAAA~TT AGp~Udh~CIk~ACTA~TCTTC T , ~ A ~ ~ T A ~  T~ T ~ & ~ G ~ ~ T ~ T C ~ S ~  3960 
ACCTGGATC~TC'ACTA~TAeTAATTCATTTATTA~TAA~-~CTTCTGGCTTCCITC~TA~A~G~G~~~~~ i ~v~,~,~ l 4OEO 
TTCAO~ WaCT~T C TA~.A~TT'TGTGTAGA~TGT  T ~ e , ~ A ~ ' I ~ T A A T G C ~ A ~ ~ T ~ ~ ~ ~ ~  T 4320 
ATATTG~ / ~GATATGAAPaTGTTA~J~TAC~ATTTCCAATATT~GAGCATATC.AAAAA~TA'O['AAAACT~GGACC.A~A~ . . . .  TAAAC~GTTAG 4440 
AA't~d~ CTCATT,'~//r I~.'CA~TCTAGTGCTA~J~TGTATAAAT~TT ~ T ~  ~ T ~ T A ~ ~ ~ ~ ~ T ~  4560 
CA~GGTTCACT~TC~GAAGCTTTAATATTTAAATAA~-a-TCATA~A~~GTAT~TA~TAT~G~G~AG~~ 4680 
TTTTTG~TGTCAAAGA~L4,~TTkTATACTATTTCCCTTGAAATTTTAAACTATAi ~ i CTTTACAGGTATi.TATAATATA~ I . ~ A ~  n i i i ~ ¢~0 
AT.A~. TAAATTATATTAAAGAACCAAAAG'I ~ 1 ~CCTGAGAATAAGAAAGTTTCAL~--'C~. TAAAATAT'~ ] t mGAAAGGCATGTTCCTCTGTCAATC~a.AAAAAGTACATGTATGTGTTGTGA 4920 
T~`~Ka`AAG. fC~CATTTGTCTAATAGCCTAATACAACATGTAGCTGAGTTTAACA~~TA~~C~ATA~TA~~T 5037 
Fig. 2. Nucleotide scqu¢~l~ o|" the 5 kb transcript of the human PCI/PC3 gent and the predicted amino acid .'a.'qucnc¢ of human PCbPC3. 
Nnmbering of the amino acids and lhe nucl~-otides is indicated  the nd of cach line. The pma0ive cteavag¢ site Ibr the signal pcptide is indicated 
by an arrow. The amphipathic =-helical structure in the carboxy-tcL'minus el" the deduced PCI/PC3 protein is underlined with a double line. The 
predicted subtilisin.likc catalytic domain is shaded and essential mino acid residues of its acti~ site are D (167). H (208) and S (382). At position 
309, the catalytically important asparagine residue iN) is present. The stop codon is marked with an asterisk. Consensus sequences for X- 
glycosylation are NHT (173-17~) and NLT (401-403), An RGD sequence is prc~¢nt front amino acid position 518 to 520. Nudcotide sequences 
corresponding 1o the consensus signals (ATTAAA and AATAAA) for polyadenylation are underlined. 
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lines of the classical type (five out of live SCLC-C cell 
lines expressed PCI/PC3) but neither of these 
transcripts could be detected in most or the SCLC cell 
We also studied the PCI/PC3 expression pattern in 
primary tumors of the lung (Table 11). Six primary 
SCLCs. live eareinoid tumors of the lung and thirteen 
loss or absence of ncuroendocrine featuresin SCLC-V 
cell lines is an established phenomenon [25]. Variant 
SCLC call line NCI-H446 seemed to be an exception 
S '  : ............ ~ " • neumcndocrine 
marke~ 7B2andGRP! We do not have a clear explana- 
tion Ibrlhis apparent dlscrepaney yet, but ~ve slx-culate 
that SCLC-V cell lines not invariably lose all their neu- 
roendocrine f atures completely, In this context, the 
very low PCI/PC3 expression i  the SCLC-V cell lines 
NCI-H526 and NL-SCLC3 might be xplained in a 
similar manner, since NCI-H526 does express 7B2 but 
not GRP [251, Finally, it is important to note here that 
of the two PCI/PC3 transcripts he one of 5 kb was the 
more abundant one in the SCLC-C celt lines. This is in 
contrast with results of PCI/PC3 expression studies in 
which other cell types were used [4,6,81. 
Table I 
Expn.~sioa o1" the PCI;PC3 gene in human hmg carcinoma ¢¢1t lines 
Lung cancer cells Classification PCI;PC3 exprogsion 
GL C- I-M 13 SCLC-C + 
SCLC-2] H SCLC-C ÷ 
SCLC-22H SCLC-C + 
SCLC-16C SCLC-C 4- 
NCI-H249 SCLC-C * 
GLC-I SCLC-V - 
SCLC-|6V SCLC-V 
NCI-H82 SCLC-V - 
NCI-N417 SCLC-V - 
NCI-H524 SCLC-V - 
NCI-H526 SCLC-V ~l*) 
NCl-H446 SCLC-V + 
NL-SCLC3 SCLC-V -1.) 
÷ Compar~.~ to expn.'ssion levels of |~21.:PC3 mRNAs as in F'ig. 
1, lane 1. 
- No expressioo f Pt'?I/PC3 gene, even not after prolonged ex- 
posure of the X-ray films. 
t*) After prolonged 020 h) exposure of X-nly films a weak signal 
comparable to that in Fig. I. lane 2, became v2!ble. 
86 
el (ne ttve earcmoitt tumors or the lung a p ~  to 
exhibit very h~h levels or PCI/PC3 exp~mn,  In the 
fifth one, expression was Io~er but still ~m~mble  to 
the levels observed in the SCLC-C oell lines. All primal3, 
non-SCLCs wen: negative for PCA~PC3 eatpression. 
Like in the SCLC-C cell lines, both the 3 kb and 5 kb 
PCI/PC3 trau~ripts were expressed in primary SCLCs 
and careinoid tumors of the lung, with the 5 kb mRNA 
always the moee abundant. 
Based upon the results or the expression studies, a
primary ea~eeinoid tumor of the lung ,.~s selected as 
mRNA sourt'¢ for experiments toobtain cDNAs corre- 
sponding to the 5 kb PC1/PC3 transcript, U~ng mRNA 
isolated from such a carcinoid tumor of the lung (tumor 
10605), a eDNA library in 3gtll was constructed as 
de~rib.-d in ,section 2, Screening of about t~,000 pla- 
ques of this librar3, with the 2.6 kb mouse PCI/PC3 
eDNA probe resulted in the identification of about 50 
positive baeteriophab~ dones~ From these, clones ~re  
sek'cted that hybridized to the ~ half as wall as to the 
Y half o1" the mouse PCI/PC3 eDNA of 2,6 kb. Six 
clones ~a:l*e identified on the Ixlsis of the~ selection 
criteria. They were plaque-purified and designated 
,LICI-XJC6. Upon isolation of DNA I'rom these bacte- 
rioptzagc stocks, tl',e ioscrl DNAs ,vclx" .~ludi¢~! by 
"i a01e i l  
Expn..'s.sion 1" the PCI;PC3 gone in t~rim,try i~uman lu g Ironers 
Ihimary tumors Tumors Levels of PCI/PC3 
tes'ted expression 
++4-+ 4 -+ 4- 4 - [ -  --  
SCLCs ,~, q 2 0 2 2 
noa-SCLCs 
- adenocavcinomas 0 0 0 0 0 6 
- squamotts ell ~rcinomas 7 0 0 0 0 7 
Carcinoid tumors 5 ,1 0 I 0 0 
++++ Comp::rex to expresslo~ levels of PCI/PC3 mRNAs as in Fig, 
I, tanL~ 5 and 6. 
++ ComNIrcs to expression levels of PCt/PC3 mRNAs as in Fig. I, 
lane 3. 
+ Compares (o expression levels of PCIlPC3 mRNAs as in Fig. I, 
lane I. 
- No expression of the PCI/PC3 gene. 
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mouse PC1/PC3 
human POllPO3 
pr41pro ©lt l lV l lo  mllldll l AH~I 
+ 
"llll~,! 911~ . 9S~,. l l lOq~ . 
1 kll 
D.g ,  . . . .  
Fig,+ 3. Sc~em,llC ~pmse!Uation f,he human 5 kb sad the mo.u~ 3kb I.ran,¢.ript~, or the PCIJPC3 ilene and the mrrt'q~oadtnll deduced l 'C ln '~l  
protean, the ¢oum8 region, are repre,entea as nexus m which the venous domains are indicated. Cormqtondinil !t' llOa, in both im~m 
connoted by dotl~ Itnett and pereentnll¢, ofamlno acid g'queno~ similarity are 8{veu. The tatrboxy.lennimd It phipalhi¢ =-helical ~ln~ulr~ (AHS| 
nre Indicated m, b]uck t~oxe.. Polyudenylntlon site, found in mott~e PCi/PC3 transcripts r;'l are indhaaed by eno~t. 
restriction enzyme analysis. ).JC6 ~+,~ selected I'or fur- 
ther studies, because it contained the largest insert. 
Restriction e ,~me analysis revealed that the insert or 
Mc6  contained three internal E~R! sites: the Ibur 
EcoR! tYagments were subcloned in pKLI~I9 or 
pGEM-3Zt~+) and the nudcotide sequence of these 
DNAs was determined. The order and orientation of 
the four Ecogl fragments could be established by direct 
sequencing of the phage insert DNA. The nucl¢otide 
sequence data are shown in Fig, 2, The PCI/PC3 ~DNA 
insert o1"~C6 appeared to be $037 nudcotides loaf, As 
it contained no polydA-tail, the corresponding trans- 
cript is presumably still a few hundred bases larger, 
including the poly(Abtail. Analysis of the nudeotide 
sequence r ~+¢ah.'d an open reading frame Ibr a protein 
of 753 amino acid residues: exactly the same number of 
residues as the protein deduced from the 3 kb mouse 
PCI/PC3 mRNA (7: see ulso 6,8) and with similar pro- 
tein domains. In Fig. 3, we have indicated the "prepro', 
catalytic and middle domain and the amphipathic a- 
helical structure (AHS). Overall amino acid sequence 
similarity between the pg'dicted human and mouse 
PC I/PC3 proteins i  about 92%. In the "prepi'o' domain, 
the subtilis;,n-like catalytic domain, the middle domain 
and the remainitxg carboxy-tenninal domain, the .~r- 
centtq~s are 89%, 98%, 95% and ~0%, resl~..'ctively (Fig. 
3). The subtilisin-like domain of human PCI/PC3 con- 
tains five cysteine residues which are eonserv_~ in 
human furls and the prohonnone processing enzymes 
encoded by the KEXI gene of A'lu3"~eron~r~.s la¢lis and 
the KE,~ gene of Saccharomyce~ cerevisiae. In earlier 
computer-assisted molecular modelling studies, xs~ have 
proposed a 3D model for human furls and the two 
yeast-processing enzymes and suggested that in furls 
two disulphide bridges may be formed and in the yeast 
enzymes three [15]. Based upon the sequence data pre- 
sented here, we also predict wo such disulphide bonds 
in human PCI/PC3. In contrast to the predicted amino 
acid sequence of mouse PCI/PC3 which contains three 
potential sites for N-glycosylation [6-8], that of human 
PCI/PC3 contains only two such potential sites. Both 
of these, NHT (173-175) and NLT (401-403) (Fig. 2), 
are located in the subtilisin-like catalytic domain. Like 
in mouse PCI/PC3 [6-8], human and mouse PC2 [4,5], 
human I.'+,I I, mouse [lOl and mt furin 11.21, the trlrmt>- 
tide ,co n++,t+us recolFdtion seqm ROD. which is 
found m a numl~r Of~lracellular matrix IXOtehn mxl 
.~ms implicat~l in c~ll adh~lon, is ~ t  in humu 
PCI/PC3 at amino acid positions $18 to 520. The ROD 
sequence is not found in the two yeast ~ en- 
zymes. 
In summary, we conclude front our studies that irma. 
cr!ption of the human !~1/!~3 8¢n¢ in lea8 tarao¢ ellt 
with n©umendocnne features nn~tlts m the ~t loa  
el two major t run~pl~ one of 3 kb und one of $ kl~ 
with a prefercn~ for the $ kb ~ Takinsinto 
count the published nudcotlde sequence data of  the 3 
kb transcript of mouse I~ I~ and the nudcolid© 
sequence data of human I~I/PC3 IXCscmed he~ 
conclude that the molecular basis for the size difference 
bct~-¢n the t~ PCI/PC3 mRNAs in both mammals i
due to differences in the length of the Y untranslated 
region and that both the 3 kb and $ kb PCl~PC3 trans- 
cripts encode the same protein, Thus, the d i~gea~ 
obsenx'd in transcription of the I~l/F~_3 gen¢ does not 
generate a dix~rsity in PCI~PC3 proprotcin processing 
enzymes` Assuming that the genes for human and 
mouse PCI/PC3 are single copy genes [7], the 3 kb and 
5 kb transcripts likely orig;,;tte from the- same gen¢. 
ml~NAs transcribed t'ro~ the same 8ene and va~yP,.,.g i a 
size due to divergence in length of their 3' ent rus ted  
regmn are not ~am~sual and could affe..-, . '~;~A staF,~iiL~- 
in a positix~ way~ it is conceivable t~mt im higher le~xqs 
of the 5 kb transcript in thehuman lung tun~or cells as 
compared to the 3 kb species hould be attributed to 
this, at least in part, Ahab ,  s of the rates according to 
which both transcripts are s~athesized could be instru- 
mental in resolving this matter more conclusix~ely. 
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